<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
   <channel>
      <title>Dermatology News</title>
      <link>http://poznaisebya.com/newseng/dermatology-news/</link>
      <description>Dermatology News</description>
      <language>en-en</language>
      <webMaster>padayatra@bk.ru</webMaster>
      <copyright>http://poznaisebya.com/newseng</copyright>
      <pubDate>Tue, 02 Dec 2008 16:05:30 GMT.</pubDate>
      <lastBuildDate>Mon, 23 Jun 2008 16:00:09 GMT</lastBuildDate>
      <image>
         <title>Dermatology News</title>
         <url>http://poznaisebya.com/newseng/i/logo.png</url>
         <link>http://poznaisebya.com/newseng/dermatology-news/</link>
      </image>

      <item>
         <title>CuraGen Announces Expansion Of CR011-vcMMAE Phase II Trial In Melanoma</title>
         <link>http://poznaisebya.com/newseng/dermatology-news/news_2008-06-23-16-00-09-644.html</link>
         <description>CuraGen Corporation (Nasdaq: CRGN),  a clinical-stage biopharmaceutical company focused on oncology,  announced that its Phase II Trial evaluating CR011-vcMMAE for the treatment of patients with unresectable Stage III or Stage IV melanoma has met the efficacy criteria for advancement to the second stage of enrollment.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/dermatology-news/news_2008-06-23-16-00-09-644.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Mon, 23 Jun 2008 16:00:09 GMT</pubDate>
      </item>

      <item>
         <title>Cloned Immune Cells Treat Skin Cancer</title>
         <link>http://poznaisebya.com/newseng/dermatology-news/news_2008-06-23-16-00-07-117.html</link>
         <description>&quot;A cancer patient has made a full recovery after being injected with billions of his own immune cells in the first case of its kind, &quot; The Daily Telegraph reported.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/dermatology-news/news_2008-06-23-16-00-07-117.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Mon, 23 Jun 2008 16:00:07 GMT</pubDate>
      </item>

      <item>
         <title>As Summer Heats Up, New Survey Reveals Need For Effective Sweat Treatments</title>
         <link>http://poznaisebya.com/newseng/dermatology-news/news_2008-06-20-05-20-03-317.html</link>
         <description>As the thermometer rises,  so does the humidity. For many,  the humidity can be annoying,  but for the nearly 8 million Americans who suffer from a treatable condition called hyperhidrosis(1),  or excessive sweating,  the humidity can be unbearable.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/dermatology-news/news_2008-06-20-05-20-03-317.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Fri, 20 Jun 2008 05:20:03 GMT</pubDate>
      </item>

      <item>
         <title>More Research Needed To Understand Scleroderma</title>
         <link>http://poznaisebya.com/newseng/dermatology-news/news_2008-06-19-02-00-08-620.html</link>
         <description>With an estimated 14 million cases worldwide,  you would think more would be known about scleroderma,  a chronic,  debilitating disease that can lead to the hardening and tightening of skin and connective tissue.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/dermatology-news/news_2008-06-19-02-00-08-620.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Thu, 19 Jun 2008 02:00:08 GMT</pubDate>
      </item>

      <item>
         <title>Senesco Expands On Preclinical Multiple Myeloma Findings</title>
         <link>http://poznaisebya.com/newseng/dermatology-news/news_2008-06-19-02-00-07-412.html</link>
         <description>Senesco Technologies,  Inc. (&quot;Senesco&quot; or the &quot;Company&quot;) (Amex: SNT) announced further details of its continuing preclinical multiple myeloma research.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/dermatology-news/news_2008-06-19-02-00-07-412.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Thu, 19 Jun 2008 02:00:07 GMT</pubDate>
      </item>

      <item>
         <title>Dermatologists Report Increased Use Of Biologics In The Treatment Of Psoriasis</title>
         <link>http://poznaisebya.com/newseng/dermatology-news/news_2008-06-19-02-00-06-737.html</link>
         <description>BioTrends Research Group,  Inc. released its third annual TreatmentTrends (TM): Psoriasis publication,  providing insight into the management of psoriasis.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/dermatology-news/news_2008-06-19-02-00-06-737.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Thu, 19 Jun 2008 02:00:06 GMT</pubDate>
      </item>

      <item>
         <title>Study Supports Possible Use Of Leukine R As A Potential Adjuvant Therapy For High-Risk Melanoma Patients</title>
         <link>http://poznaisebya.com/newseng/dermatology-news/news_2008-06-19-02-00-05-833.html</link>
         <description>Results from an adjuvant trial in high-risk melanoma patients demonstrated that a majority of patients treated with Leukine(R) (sargramostim) achieved disease-free and/or overall survival.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/dermatology-news/news_2008-06-19-02-00-05-833.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Thu, 19 Jun 2008 02:00:05 GMT</pubDate>
      </item>

      <item>
         <title>Another New Wrinkle In Treating Skin Aging</title>
         <link>http://poznaisebya.com/newseng/dermatology-news/news_2008-06-19-02-00-04-444.html</link>
         <description>Topical applications of a naturally occurring fat molecule have the potential to slow down skin aging,  whether through natural causes or damage,  researchers report.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/dermatology-news/news_2008-06-19-02-00-04-444.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Thu, 19 Jun 2008 02:00:04 GMT</pubDate>
      </item>

      <item>
         <title>Restless Leg Syndrome Relief Found In Rotigotine Skin Patch</title>
         <link>http://poznaisebya.com/newseng/dermatology-news/news_2008-06-17-22-22-23-854.html</link>
         <description>Patients with restless leg syndrome (RLS) - the irresistible urge tomove one&#039;s body to limit uncomfortable or odd sensations - may get somerelief during day and night by using skin patches that contain the drugrotigotine.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/dermatology-news/news_2008-06-17-22-22-23-854.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Tue, 17 Jun 2008 22:22:23 GMT</pubDate>
      </item>

      <item>
         <title>Malignant Melanoma Classification Given Additional Genetic Component</title>
         <link>http://poznaisebya.com/newseng/dermatology-news/news_2008-06-17-22-21-42-207.html</link>
         <description>Existing melanoma classifications have been refined by a team at theUniversity of California San Francisco according to an article releasedon June 2,  2008 in the open access journal PLoS Medicine.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/dermatology-news/news_2008-06-17-22-21-42-207.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Tue, 17 Jun 2008 22:21:42 GMT</pubDate>
      </item>

   </channel>
</rss>
